Peter Moritz Becher
University of Hamburg
14 Papers
15 Citations
Peter Moritz Becher is an academic researcher from University of Hamburg. The author has contributed to research in topics: Medicine & Cardiogenic shock. The author has an hindex of 6, co-authored 14 publications.
Chat about Author
Papers
Unloading of the Left Ventricle During Venoarterial Extracorporeal Membrane Oxygenation Therapy in Cardiogenic Shock
Benedikt Schrage,Daniel Burkhoff,Nicole Rübsamen,Peter Moritz Becher,Michael Schwarzl,Alexander M. Bernhardt,Hanno Grahn,Edith Lubos,Gerold Söffker,Peter Clemmensen,Hermann Reichenspurner,Stefan Blankenberg,Dirk Westermann +12 more
TL;DR: The strategy of percutaneous LV unloading using a transaortic LV assist device in combination with VA-ECMO improved outcome in an all-comers cohort compared to established risk scores.
145
Adherence to Mediterranean diet, high-sensitive C-reactive protein, and severity of coronary artery disease: Contemporary data from the INTERCATH cohort.
Christoph Waldeyer,Fabian J. Brunner,Julian Braetz,N Ruebsamen,Birgit-Christiane Zyriax,Christopher Blaum,Friederike Kroeger,Rebecca Kohsiack,Benedikt Schrage,Christoph Sinning,Peter Moritz Becher,Mahir Karakas,Tanja Zeller,Dirk Westermann,Karsten Sydow,Stefan Blankenberg,Moritz Seiffert,Renate B. Schnabel +17 more
TL;DR: An independent association of adherence to MD with a less complex CAD is found and this results strengthen the evidence for the protective effect of an MD pattern in CVD prevention.
46
Procedural volume and outcomes in patients undergoing VA-ECMO support
Peter Moritz Becher,Alina Goßling,Benedikt Schrage,Raphael Twerenbold,Nina Fluschnik,Moritz Seiffert,Alexander M. Bernhardt,Hermann Reichenspurner,Stefan Blankenberg,Dirk Westermann +9 more
TL;DR: In this analysis of more than 10,000 VA-ECMO procedures for cardiogenic shock, the majority of implantations were performed at hospitals with the lowest annual volume, and Thirty-day in-hospital mortality and likelihood for complications were higher at universities with the highest annual VA- ECMO volume.
45
Eligibility for mechanical circulatory support devices based on current and past randomised cardiogenic shock trials.
B. Schrage,B. Schrage,Benedikt N Beer,Gianluigi Savarese,Salim Dabboura,Isabell Yan,Jonas Sundermeyer,Peter Moritz Becher,Hanno Grahn,Moritz Seiffert,Alexander M. Bernhardt,Holger Thiele,Jacob E. Møller,Stefan Kluge,Hermann Reichenspurner,Paulus Kirchhof,Stefan Blankenberg,Dirk Westermann +17 more
TL;DR: In this paper, the authors investigated the eligibility of MCS patients in randomised controlled trials (RCTs) and found that only 31.8% of the patients were eligible for any study and the lowest eligibility was observed for DanGer-SHOCK (11.9%) and the highest for IABP-ShOCK II (26.9%).
38
Non-immune risk predictors of cardiac allograft vasculopathy: Results from the U.S. organ procurement and transplantation network
Nina Fluschnik,B Geelhoed,Peter Moritz Becher,Benedikt Schrage,Fabian J. Brunner,Dorit Knappe,Alexander M. Bernhardt,Stefan Blankenberg,Jon A. Kobashigawa,Hermann Reichenspurner,Renate B. Schnabel,Christina Magnussen +11 more
TL;DR: In this paper, the authors aimed to identify non-immune recipient- and donor-related risk factors for the development of CAV in heart transplant patients, using multivariable-adjusted Cox regression analyses.
12